Basgenbio Inc.
- Biotech or pharma, therapeutic R&D
Biosgenbio leverages a global clinico-genomic cohort of approximately 770,000 individuals incorporating exclusive data to discover ideal novel targets through the use of deep learning.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}